Core Scientific's largest shareholder opposes an all-share sale to CoreWeave, saying the deal is undervalued
2025-08-08 11:51:34
Two Seas Capital, the largest shareholder in Core Scientific, announced it would vote against its all-share sale to CoreWeave, saying the deal was undervalued and structurally flawed. In July, CoreWeave announced the acquisition of Core Scientific, a digital infrastructure company, in an all-share deal. The deal was valued at $20.40 per share. The agreed share swap ratio would value the company at about $9 billion.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
Animoca Brands战略投资Cool Cats Group
